RecallDepth
Class II Terminated

Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 19, 2018
Posted
January 23, 2019
Recall Number
D-0381-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
181,456 bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Failed dissolution specifications

Distribution

U.S.A. nationwide

Lot / Code Info

Lot #: a) 49O005, 49O006, 49O007, 49O010, Exp 02/2019; b) 49O005, 49O009, 49O010, Exp 02/2019

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls